| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.006 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |